Aim & Scope
JNCCN – The Journal of the National Comprehensive Cancer Network is a peer-reviewed publication dedicated to improving the quality of cancer care by providing the latest information about best clinical practices, oncology outcomes, and new research initiatives to our readership. This information is provided through the publication of NCCN's Clinical Practice Guidelines in Oncology™. JNCCN also publishes review articles analyzing recommendations and detailing current oncologic practice as well as clinical research articles discussing new advances that will become standard practices in the future. Further goals are to address oncology practice at all stages and presentations, to enhance communication among oncology experts in both academic and community settings, and to provide a forum for discussion and commentary. [1]
2024
21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial.
No authors listed.
Journal of the National Comprehensive Cancer Network (JNCCN) , 2024 , pp 1-6.
Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer.
MJM van Velzen , M Pape , MAG Sprangers , ... , HWM van Laarhoven
Journal of the National Comprehensive Cancer Network (JNCCN) , 2024 , pp 1-7.
AJ Didier , L Roof , J Stevenson
Journal of the National Comprehensive Cancer Network (JNCCN) , 2024 , pp 1-7.
RB Incesu , S Morra , L Scheipner , ... , PI Karakiewicz
Journal of the National Comprehensive Cancer Network (JNCCN) , 2024 , pp 1-7.